Drug intelligence / Profile preview

PP405 topical vehicle gel

Development stage: Unknown
Lead developer: Pelage Pharmaceuticals
Administration: Topical

Overview

PP405 topical vehicle gel is a placebo control formulation used in clinical trials for PP405, a novel topical small molecule developed for the treatment of androgenetic alopecia. The vehicle gel contains the same base formulation as the active drug but without the active ingredient. It serves as a control in clinical studies evaluating the safety and efficacy of PP405.

Targets

MPC (Mitochondrial pyruvate carrier)

Beyond the preview

Go deeper on PP405 topical vehicle gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PP405 topical vehicle gel.

Explore the full profile